Publication | Open Access
Plasma visfatin levels are associated with major adverse cardiovascular events in patients with acute ST-elevation myocardial infarction
24
Citations
33
References
2015
Year
The level of plasma visfatin may be associated with risk of composite MACEs in STEMI patients, and may be useful for risk stratification.
| Year | Citations | |
|---|---|---|
Page 1
Page 1